Client Results Session by Session
S3-Leitlinie Komplementrmedizin in der Behandlung von onkologischen PatientInnen Langversion Mai 2024, AWMF-Registernummer: 032/055OL Sato S, Namisaki T, Furukawa M, Saikawa S, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Kitagawa K, Moriya K, Akahane T, Mitoro A, Hoki N, Ann T, Yoshiji H
2011 Jun;17(6):PI15-23
Otros metabolitos de la colina que se sabe que son molculas de sealizacin celular incluyen el factor activador de plaquetas (PAF) y la esfingofosfocolina
The absolute bioavailability of levocarnitine from the two oral formulations of levocarnitine, calculated after correction for circulating endogenous plasma concentrations of levocarnitine, was 15.1% 5.3% for levocarnitine tablets and 15.9% 4.9% for levocarnitine oral solution